Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 55154-7634

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 55154-7634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (1843d24f 2e80 4749 Becc 9def6c3607c7 01)

Chemical structure of Pantoprazole Sodium, showing the molecular arrangement including a pyridine ring with methoxy groups, a sulfoxide linkage, a benzimidazole ring substituted with a fluoromethoxy group, and associated sodium ion and water of hydration (1.5 H2O).*

FDA Label Image

1 (1843d24f 2e80 4749 Becc 9def6c3607c7 02)

FDA Label Image

Torrent Logo (1843d24f 2e80 4749 Becc 9def6c3607c7 03)

FDA Label Image

6ba56251 E43c 4e34 A37f 42a542550c05 00

Pantoprazole Sodium delayed-release tablets label showing 40 mg strength, containing 10 tablets. The label includes storage instructions, usage warnings, and notes this unit dose package is intended for institutional use. Manufactured by Torrent Pharmaceuticals Ltd., India, distributed by Major Pharmaceuticals in Livonia, MI, and Cardinal Health in Dublin, OH.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.